Bottom line
THY vs MSOS: the short answer
THY (Toews Agility Shares Dynamic Tactical Income ETF) and MSOS (AdvisorShares Pure US Cannabis ETF) are both etfs.
But MSOS is far broader, holding 61 positions to 1 for THY, so beyond the top names it adds exposure THY doesn't have.
MSOS is cheaper at 0.78% vs 1.04% — a difference of $26 a year per $10,000 invested.
Over five years, THY returned +1.6% a year vs −33.6% for MSOS.
Updated Nov 19, 2026
THY vs MSOS side by side
| THY | MSOS | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Fidelity | Advisorshares |
| Category | Other | Other |
| Expense ratio | 1.04% | 0.78% |
| Annual cost per $10k | $104 | $78 |
| 10-yr cost on $10k (prospectus) | $1,514 | $927 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +4.3% | +23.4% |
| 5-yr return (annualized) | +1.6% | −33.6% |
| 10-yr return (annualized) | +2.3% | — |
| Best quarter | +5.7% | +102.2% |
| Worst quarter | −3.6% | −50.4% |
| Net assets (fund) | $88.1M | $1.0B |
| Number of holdings | 1 | 61 |
| Portfolio turnover | 414% | 5% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | THY | MSOS | Difference |
|---|---|---|---|
| 2025 | +4.3% | +23.4% | −19.0% |
| 2024 | +5.3% | −46.4% | +51.7% |
| 2023 | +4.8% | −1.8% | +6.7% |
| 2022 | −5.4% | −72.3% | +66.9% |
| 2021 | −0.5% | −29.5% | +29.0% |
Source: Fund prospectus bar charts
Holdings overlap
THY and MSOS share none of their top holdings.
THY top 10
- Bbh Sweep Vehicle — 100.03%
MSOS top 10
- Curaleaf Holdings Inc — 12.32%
- Trulieve Cannabis Corp — 9.56%
- Blackrock Treasury Trust — 5.78%
- Terrascend Corp — 2.70%
- Marex Capital Markets Inc. — 2.16%
- Cantor Fitzgerald & Co. — 1.08%
- Morgan Stanley & Co. Llc — 0.94%
- Glass House Brands Inc — 0.93%
- Nomura Securities International, Inc. — 0.85%
- Cantor Fitzgerald & Co. — 0.78%
FAQ
What is the difference between THY and MSOS?
Which is cheaper, THY or MSOS?
Should I own both THY and MSOS?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.